Retraction
LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2
Paper Information
Record ID:
43021
Author(s):
Journal:
Publication Date:
September 22, 2021
Retraction Date:
March 02, 2023
(2.7 years years ago)
Subjects:
Institutions:
- Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, 530021, Nanning, Guangxi, People’s Republic of China
- Key Laboratory of Basic and Clinical Application Research for Hepatobiliary Diseases of Guangxi, 530021, Nanning, Guangxi, People’s Republic of China
- Department of Pancreatic Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, 300060, Tianjin, People’s Republic of China
- Key Laboratory of Heilongjiang Province for Cancer Prevention and Control, School of Basic Medicine, Mudanjiang Medical University, 157011, Mudanjiang, People’s Republic of China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Springer - Biomed Central (BMC)
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (60)
60
Total Citations26
Post-Retraction(43.3%)
33
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
1
Within 30 days
16
Within 1 year
0
After 2+ years
710
Days since retraction (latest)
Research progress on the interaction between long non‑coding RNAs and RNA‑binding proteins to influence the reprogramming of tumor glucose metabolism (Review)
Weizheng Wu, Kunming Wen
Oncology Reports
Open Access
Published: Jul 2022
2 citations
2 citations
230 days before retraction
LncRNA ZNF674-AS1 Hinders Proliferation and Invasion of Hepatic Carcinoma Cells through the Glycolysis Pathway
Dongliang Li, Yan Xie, Jisan Sun et al. (5 authors)
Journal of Oncology
Open Access
Published: Jul 2022
5 citations
5 citations
232 days before retraction
N6-methyladenosine modification and metabolic reprogramming of digestive system malignancies
Xianlei Cai, Chao Liang, Miaozun Zhang et al. (7 authors)
Cancer Letters
Published: Jul 2022
31 citations
31 citations
240 days before retraction
Emerging roles and potential clinical applications of long non-coding RNAs in hepatocellular carcinoma
Jiaqi Sheng, Enjun Lv, Limin Xia et al. (4 authors)
Biomedicine & Pharmacotherapy
Published: Jun 2022
11 citations
11 citations
246 days before retraction
Regulation of Gamma-Aminobutyric Acid Transaminase Expression and Its Clinical Significance in Hepatocellular Carcinoma
Xiaoqiang Gao, Xiaodong Jia, Moyan Xu et al. (8 authors)
Frontiers in Oncology
Open Access
Published: Jun 2022
10 citations
10 citations
251 days before retraction
Glycolysis-Related LINC02432/Hsa-miR-98–5p/HK2 Axis Inhibits Ferroptosis and Predicts Immune Infiltration, Tumor Mutation Burden, and Drug Sensitivity in Pancreatic Adenocarcinoma
Peng Tan, Mo Li, Zhuoran Liu et al. (6 authors)
Frontiers in Pharmacology
Open Access
Published: Jun 2022
24 citations
24 citations
255 days before retraction
Analysis of lncRNA sequences: FAM3D-AS1, LINC01230, LINC01315 and LINC01468 in endometrial cancer
Jan Bieńkiewicz, Hanna Romanowicz, Bożena Szymańska et al. (8 authors)
BMC Cancer
Open Access
Published: Mar 2022
5 citations
5 citations
338 days before retraction
CDKN3 Overcomes Bladder Cancer Cisplatin Resistance via LDHA-Dependent Glycolysis Reprogramming
Mengxuan Li, Nan Che, Yu Jin et al. (5 authors)
OncoTargets and Therapy
Open Access
Published: Mar 2022
21 citations
21 citations
366 days before retraction
Sortilin 1 regulates hepatocellular carcinoma progression by activating the PI3K/AKT signaling
S Ye, B Wang, Yanbing Zhou et al. (5 authors)
Human & Experimental Toxicology
Published: Jan 2022
4 citations
4 citations
425 days before retraction
MiR-145-5p Suppresses Hepatocellular Carcinoma Progression by Targeting ABHD17C
Linpei Wang, Xiaoqiu Ma, Youqi Chen et al. (7 authors)
ONCOLOGIE
Open Access
Published: Jan 2022
9 citations
9 citations
425 days before retraction
Quick Stats
Total Citations:
60
Years Since Retraction:
2.7 years
Open Access:
Yes
Last Checked:
Jul 24, 2025